252 related articles for article (PubMed ID: 1713878)
1. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
2. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
Yamamoto K; Sekiguchi E; Takatani O
Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
Balduini CL; Bertolino G; Noris P; Piletta GC
Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
[TBL] [Abstract][Full Text] [Related]
5. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Zucker S; Mielke CH
J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
[No Abstract] [Full Text] [Related]
6. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
7. [Megakaryocytic myelosis--clinical aspects, morphology and platelet function].
Hochhaus A; Höche D; Mindner K; Ostermann G; Meyer M
Klin Wochenschr; 1989 Jan; 67(2):51-9. PubMed ID: 2921844
[TBL] [Abstract][Full Text] [Related]
8. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
[TBL] [Abstract][Full Text] [Related]
9. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
Nishimura J; Okamoto S; Ibayashi H
Thromb Haemost; 1979 Jun; 41(4):787-95. PubMed ID: 483250
[TBL] [Abstract][Full Text] [Related]
11. [The platelet defect in myeloproliferative disorder (author's transl)].
Delobel J
Nouv Rev Fr Hematol (1978); 1976; 16(3):443-6. PubMed ID: 1012918
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.
Kaywin P; McDonough M; Insel PA; Shattil SJ
N Engl J Med; 1978 Sep; 299(10):505-9. PubMed ID: 210377
[TBL] [Abstract][Full Text] [Related]
13. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
14. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
15. The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis.
Tsantes AE; Dimoula A; Bonovas S; Mantzios G; Tsirigotis P; Zoi K; Kalamara E; Kardoulaki A; Sitaras N; Travlou A; Dervenoulas J; Vaiopoulos G
Thromb Res; 2010 Feb; 125(2):142-6. PubMed ID: 19664802
[TBL] [Abstract][Full Text] [Related]
16. Altered in vitro functions of platelets prepared by the Haemonetics blood processor.
Ts'ao CH; Wirman JA; Ruder EA
J Lab Clin Med; 1975 Aug; 86(2):315-25. PubMed ID: 1151154
[TBL] [Abstract][Full Text] [Related]
17. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
18. Primary thrombocythemia in the young patient.
Hoagland HC; Silverstein MN
Mayo Clin Proc; 1978 Sep; 53(9):578-80. PubMed ID: 567265
[TBL] [Abstract][Full Text] [Related]
19. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma].
Terada H; Ohshima M
Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195
[TBL] [Abstract][Full Text] [Related]
20. Studies on platelet aggregation using the Born method in normal and uraemic dogs.
Mischke R; Schulze U
Vet J; 2004 Nov; 168(3):270-5. PubMed ID: 15501144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
